Myeloperoxidase
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | ||
| + | <StructureSection load='1myp' size='350' side='right' caption='Dog glycosylated myeloperoxidase dimer: heavy chain (pink and yellow), light chain (grey and green) containing heme complex with Ca+2 ions (green) (PDB entry [[1myp]])' scene=''> | ||
== Function == | == Function == | ||
'''Myeloperoxidase''' (MPO) catalyzes the production of HOCl from hydrogen peroxide and chloride ion during the neutrophil respiratory burst. The hypochlorous acid is used by the neutrophil to kill bacteria and other pathogens<ref>PMID:10519157</ref>. MPO is a dimer consisting of 2 light chains and two variable-length heavy chains. MPO has a heme pigment which causes its green color in secretions like mucus which are rich in neutrophils. | '''Myeloperoxidase''' (MPO) catalyzes the production of HOCl from hydrogen peroxide and chloride ion during the neutrophil respiratory burst. The hypochlorous acid is used by the neutrophil to kill bacteria and other pathogens<ref>PMID:10519157</ref>. MPO is a dimer consisting of 2 light chains and two variable-length heavy chains. MPO has a heme pigment which causes its green color in secretions like mucus which are rich in neutrophils. | ||
| Line 8: | Line 9: | ||
== Disease == | == Disease == | ||
MPO is an important pathogenic factor in glomerular and tubulointestitial diseases<ref>PMID:14633118</ref>. MPO polymorphism is associated with increased risk of Alzheimer's disease<ref>PMID:26279325</ref>. | MPO is an important pathogenic factor in glomerular and tubulointestitial diseases<ref>PMID:14633118</ref>. MPO polymorphism is associated with increased risk of Alzheimer's disease<ref>PMID:26279325</ref>. | ||
| - | + | </StructureSection> | |
==3D structures of myeloperoxidase== | ==3D structures of myeloperoxidase== | ||
Revision as of 09:07, 30 July 2017
| |||||||||||
3D structures of myeloperoxidase
Updated on 30-July-2017
1myp – MPO – dog
1mhl, 1cxp – hMPO C – human
3f9p - hMPO
1qo4 - MPO – Arabidopsis thaliana
1d2v – hMPO C + Br
1d5l – hMPO + CN
1d7w - hMPO + CN + Br
1dnu - hMPO + SCN
1dnw - hMPO + CN + SCN
3zs0, 3zs1, 4c1m - hMPO + inhibitor
4dl1 - hMPO + thioxanthine
4ejx - hMPO + ceruplasmin
References
- ↑ Klebanoff SJ. Myeloperoxidase. Proc Assoc Am Physicians. 1999 Sep-Oct;111(5):383-9. PMID:10519157
- ↑ Friedrich R, Fuentes-Prior P, Ong E, Coombs G, Hunter M, Oehler R, Pierson D, Gonzalez R, Huber R, Bode W, Madison EL. Catalytic domain structures of MT-SP1/matriptase, a matrix-degrading transmembrane serine proteinase. J Biol Chem. 2002 Jan 18;277(3):2160-8. Epub 2001 Nov 5. PMID:11696548 doi:10.1074/jbc.M109830200
- ↑ Malle E, Buch T, Grone HJ. Myeloperoxidase in kidney disease. Kidney Int. 2003 Dec;64(6):1956-67. PMID:14633118 doi:http://dx.doi.org/10.1046/j.1523-1755.2003.00336.x
- ↑ Lazarevic-Pasti T, Leskovac A, Vasic V. Myeloperoxidase Inhibitors as Potential Drugs. Curr Drug Metab. 2015;16(3):168-90. PMID:26279325

